About this trial
The goal of this trial is to evaluate use of brain computer interfaces (BCI) at home for children with severe severe physical disabilities. The main questions it aims to answer are:
1. Can a home BCI program enable children with disabilities to achieve personalized life participation goals? 2. Can a home BCI program promote implementation reach?
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 5-18 years
Severe motor impairment including inability to walk and minimal functional hand use, and/or;
Severe communication impairment
Ability to follow simple instructions and attend to simple tasks
Disqualifiers
Epileptic encephalopathy
Unstable epilepsy, or
Brain imaging incompatible with BCI functionality
Trial design
Single group
Treatments tested in this trial
Brain computer interface
DeviceFamilies will first complete an in-person visit to review available activities, set their first goals, and learn to use BCI independently. A BCI "kit" will be given to each family, with a headset and the equipment and software required to pursue their identified goals. Following this, families will participate in 12 virtual sessions over 3-6 months. Scheduling will be flexible to accommodate complex family needs. Daily online support will be provided via a messaging application. Participants who choose to continue using BCI beyond 12 sessions will be provided kits and supported.
Treatment groups
Trial outcomes
Primary outcomes
Canadian Occupational Performance Measure
The primary effectiveness outcome is achievement of child and family-identified participation-based goals, as measured by the Canadian Occupational Performance Measure (COPM). Participants/families will set 3-5 goals, and then score the Importance, Performance, and Satisfaction with each goal on a 1-10 scale.
Implementation Reach
The primary implementation outcome is the proportion of children recruited from equity-deserving groups. A baseline survey will capture comprehensive demographics.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.